1217 — China Innovation Investment Balance Sheet
0.000.00%
Last trade - 00:00- HK$153.62m
- -HK$120.68m
- HK$69.68m
Annual balance sheet for China Innovation Investment, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 341 | 332 | 334 | 331 | 275 |
| Net Total Receivables | 1.62 | 1.64 | 1.88 | 2.78 | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 344 | 335 | 337 | 335 | 351 |
| Net Property, Plant And Equipment | 1.34 | 0.831 | 2.56 | 1.59 | 0.609 |
| Long Term Investments | |||||
| Total Assets | 613 | 564 | 550 | 549 | 703 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.21 | 0.77 | 1.17 | 5.39 | 102 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.68 | 0.77 | 2.55 | 5.87 | 102 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 611 | 563 | 548 | 543 | 601 |
| Total Liabilities & Shareholders' Equity | 613 | 564 | 550 | 549 | 703 |
| Total Common Shares Outstanding |